Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.

The only oral drug available for the treatment of leishmaniasis is miltefosine, described and approved for visceral leishmaniasis in India. Miltefosine is under evaluation for the treatment of cutaneous leishmaniasis in the Americas although its efficacy for the treatment of human visceral leishmani...

Full description

Bibliographic Details
Main Authors: Juliana Q Reimão, Jordana C Oliveira, Cristiana T Trinconi, Paulo C Cotrim, Adriano C Coelho, Silvia R B Uliana
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-02-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC4332486?pdf=render
_version_ 1811266017671774208
author Juliana Q Reimão
Jordana C Oliveira
Cristiana T Trinconi
Paulo C Cotrim
Adriano C Coelho
Silvia R B Uliana
author_facet Juliana Q Reimão
Jordana C Oliveira
Cristiana T Trinconi
Paulo C Cotrim
Adriano C Coelho
Silvia R B Uliana
author_sort Juliana Q Reimão
collection DOAJ
description The only oral drug available for the treatment of leishmaniasis is miltefosine, described and approved for visceral leishmaniasis in India. Miltefosine is under evaluation for the treatment of cutaneous leishmaniasis in the Americas although its efficacy for the treatment of human visceral leishmaniasis caused by Leishmania infantum chagasi has not been described. Drug efficacy for visceral leishmaniasis is ideally tested in hamsters, an experimental model that mimics human disease. Luciferase has been validated as a quantitative tool for the determination of parasite burden in experimental leishmaniasis. However, there are no reports of luciferase detection in the model of progressive visceral leishmaniasis in hamsters. Therefore, the aims of this study were to generate recombinant Leishmania infantum chagasi expressing the luciferase gene (Lc-LUC), characterize the biological properties of this transgenic line as compared with the wild-type parasites and evaluate miltefosine effectiveness in Lc-LUC infected hamsters.A transgenic line containing a luciferase encoding gene integrated into the ribosomal DNA locus was obtained and shown to produce bioluminescence which correlated with the number of parasites. Lc-LUC growth curves and susceptibility to pentavalent antimony and miltefosine in vitro were indistinguishable from the wild-type parasites. The effectiveness of pentavalent antimony was evaluated in Lc-LUC infected hamsters through bioimaging and determination of Leishman Donovan Units. Both methods showed concordant results. Miltefosine was effective in the treatment of Lc-LUC-infected hamsters, as demonstrated by the reduction in parasite burden in a dose-dependent manner and by prolongation of animal survival.Luciferase expressing parasites are a reliable alternative for parasite burden quantification in hamsters with advantages such as the possibility of estimating parasite load before drug treatment and therefore allowing distribution of animals in groups with equivalent mean parasite burden. Miltefosine was effective in vivo in an L. infantum chagasi experimental model of infection.
first_indexed 2024-04-12T20:34:27Z
format Article
id doaj.art-fadedb336b324e0bb5c88a70efab4537
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-04-12T20:34:27Z
publishDate 2015-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-fadedb336b324e0bb5c88a70efab45372022-12-22T03:17:39ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352015-02-0192e000355610.1371/journal.pntd.0003556Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.Juliana Q ReimãoJordana C OliveiraCristiana T TrinconiPaulo C CotrimAdriano C CoelhoSilvia R B UlianaThe only oral drug available for the treatment of leishmaniasis is miltefosine, described and approved for visceral leishmaniasis in India. Miltefosine is under evaluation for the treatment of cutaneous leishmaniasis in the Americas although its efficacy for the treatment of human visceral leishmaniasis caused by Leishmania infantum chagasi has not been described. Drug efficacy for visceral leishmaniasis is ideally tested in hamsters, an experimental model that mimics human disease. Luciferase has been validated as a quantitative tool for the determination of parasite burden in experimental leishmaniasis. However, there are no reports of luciferase detection in the model of progressive visceral leishmaniasis in hamsters. Therefore, the aims of this study were to generate recombinant Leishmania infantum chagasi expressing the luciferase gene (Lc-LUC), characterize the biological properties of this transgenic line as compared with the wild-type parasites and evaluate miltefosine effectiveness in Lc-LUC infected hamsters.A transgenic line containing a luciferase encoding gene integrated into the ribosomal DNA locus was obtained and shown to produce bioluminescence which correlated with the number of parasites. Lc-LUC growth curves and susceptibility to pentavalent antimony and miltefosine in vitro were indistinguishable from the wild-type parasites. The effectiveness of pentavalent antimony was evaluated in Lc-LUC infected hamsters through bioimaging and determination of Leishman Donovan Units. Both methods showed concordant results. Miltefosine was effective in the treatment of Lc-LUC-infected hamsters, as demonstrated by the reduction in parasite burden in a dose-dependent manner and by prolongation of animal survival.Luciferase expressing parasites are a reliable alternative for parasite burden quantification in hamsters with advantages such as the possibility of estimating parasite load before drug treatment and therefore allowing distribution of animals in groups with equivalent mean parasite burden. Miltefosine was effective in vivo in an L. infantum chagasi experimental model of infection.http://europepmc.org/articles/PMC4332486?pdf=render
spellingShingle Juliana Q Reimão
Jordana C Oliveira
Cristiana T Trinconi
Paulo C Cotrim
Adriano C Coelho
Silvia R B Uliana
Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
PLoS Neglected Tropical Diseases
title Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
title_full Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
title_fullStr Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
title_full_unstemmed Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
title_short Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
title_sort generation of luciferase expressing leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging
url http://europepmc.org/articles/PMC4332486?pdf=render
work_keys_str_mv AT julianaqreimao generationofluciferaseexpressingleishmaniainfantumchagasiandassessmentofmiltefosineefficacyininfectedhamstersthroughbioimaging
AT jordanacoliveira generationofluciferaseexpressingleishmaniainfantumchagasiandassessmentofmiltefosineefficacyininfectedhamstersthroughbioimaging
AT cristianattrinconi generationofluciferaseexpressingleishmaniainfantumchagasiandassessmentofmiltefosineefficacyininfectedhamstersthroughbioimaging
AT pauloccotrim generationofluciferaseexpressingleishmaniainfantumchagasiandassessmentofmiltefosineefficacyininfectedhamstersthroughbioimaging
AT adrianoccoelho generationofluciferaseexpressingleishmaniainfantumchagasiandassessmentofmiltefosineefficacyininfectedhamstersthroughbioimaging
AT silviarbuliana generationofluciferaseexpressingleishmaniainfantumchagasiandassessmentofmiltefosineefficacyininfectedhamstersthroughbioimaging